MSLN and ovarian carcinoma: To increase the effectiveness, infiltration, persistence and proliferation of CAR-T cells in ovarian cancer, Liang et al. [126] created a unique tandem CAR expressing an anti-FOLR1 scFv, an anti-MSLN scFv and two peptide sequences of IL-12.